Ferma's Agentic Workflows automate pharma portfolio strategy intelligence, mapping pipeline gaps, screening M&A targets, and tracking the competitive landscape from pre-clinical through commercial - synthesized into finished strategic deliverables your team can act on.
Pharma Portfolio Decisions Are Made on Incomplete Pictures
Pharma portfolio strategy decisions require the full external landscape, what competitors are building, where pipeline white spaces exist, which mechanisms are crowded, which assets are available for M&A or licensing.
Assembling that view manually across multiple databases takes weeks, for a snapshot that's outdated before the portfolio review begins. That's not a data problem. It's a synthesis problem that a purpose-built pharma portfolio intelligence platform should solve automatically.
Pharma Portfolio Strategy Agentic Workflows
Finished Deliverables for Every Portfolio Intelligence Use Case
Landscape Assessment
Competitive Drug Landscape
Target / Indication Gap Assessment
Portfolio Strategy Agentic Workflow
IP / Patent Landscape
Opportunity Screener
We finally have a single view across our pipeline and the competitive landscape — without someone spending a week stitching it together before every portfolio review.
Executive Director
Portfolio Strategy, Top 20 Pharma
See the Full Pharma Portfolio Landscape Before You Set the Strategy.
Can Ferma replace EvaluatePharma for portfolio strategy?
EvaluatePharma provides raw data exports for pharma portfolio analysis, your team still builds the picture from scratch. Ferma's pharma portfolio strategy Agentic Workflows produce finished portfolio gap analyses, pipeline-to-asset maps, and M&A screening packages directly, using continuously updated data across 23,000+ drugs and 35,000+ clinical trials, without the manual assembly step.
What Agentic Workflows does Ferma run for portfolio strategy teams?
Ferma runs six Agentic Workflows for pharma portfolio strategy teams: Landscape Assessment, Competitive Drug Landscape, Target / Indication Gap Assessment, IP / Patent Landscape, Opportunity Screener, and Portfolio Strategy Agentic Workflow. All run within the same platform your CI and BD teams use, so portfolio reviews, competitive tracking, and M&A screening share a single source of truth rather than sitting across separate tools and exports.
How does Ferma handle IP and patent data for portfolio decisions?
Ferma's IP / Patent Landscape Agentic Workflow produces a structured brief covering expiry dates, freedom-to-operate, IPR challenges, and exclusivity risks - not a raw database export your team must interpret and format. Patent risk is assessed within the same pharma portfolio intelligence platform as your competitive landscape and pipeline workflows, so IP exposure, clinical positioning, and deal feasibility can all be reviewed in a single context.
